发明名称 |
Pharmaceutical for oral delivery comprising MGBG and methods of treating disease |
摘要 |
Disclosed herein are new oral pharmaceutical compositions of MGBG and related polyamine analogs, polyamine biosynthesis inhibitors, polyamine inhibitors of AMD-I and regulators of osteopontin, and their application for the treatment of disease. |
申请公布号 |
US9616035(B2) |
申请公布日期 |
2017.04.11 |
申请号 |
US201314063541 |
申请日期 |
2013.10.25 |
申请人 |
PATHOLOGICA, LLC |
发明人 |
McKearn John;Blitzer Jeremy |
分类号 |
A61K31/155;A61K9/20;A61K9/48;A61K31/13 |
主分类号 |
A61K31/155 |
代理机构 |
|
代理人 |
Hathaway Cynthia |
主权项 |
1. A method of treating, or delaying the onset or development of, multiple sclerosis, comprising administering to a subject in need thereof about 25 mg/day to about 350 mg/day of an oral pharmaceutical composition comprising MGBG and at least one pharmaceutically acceptable excipient. |
地址 |
San Francisco CA US |